Pityriasis versicolor. 2002

A K Gupta, and R Bluhm, and R Summerbell
Department of Medicine, Sunnybrook and Women's College Health Science Center, Toronto, Ontario, Canada. agupta@execulink.com

Pityriasis versicolor is a common superficial fungal infection of the skin. It is caused by Malassezia spp., which are normal human saprophytes. Under certain conditions, both exogenous and endogenous, the fungus can convert from a yeast to a pathogenic mycelial form. This alteration results in mild inflammation of the skin, and in characteristic clinical and histological changes. The taxonomy of Malassezia spp. has recently been modified to include six obligatorily lipophilic species, all of which can be found on human skin, plus one non-obligatorily lipophilic species, which only rarely colonizes human hosts. OBJECTIVE At the conclusion of this learning activity, participants should be aware of the role of Malassezia in the development of pityriasis versicolor, the clinical and histological changes arising from this dermatosis, and the diagnosis and treatment of this disorder.

UI MeSH Term Description Entries
D008290 Malassezia A mitosporic fungal genus that causes a variety of skin disorders. Malassezia furfur (Pityrosporum orbiculare) causes TINEA VERSICOLOR. Pityrosporum,Pityrosporum ovale,Saccharomyces ovalis,Malassezia furfur,Pityrosporum orbiculare
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000279 Administration, Cutaneous The application of suitable drug dosage forms to the skin for either local or systemic effects. Cutaneous Drug Administration,Dermal Drug Administration,Drug Administration, Dermal,Percutaneous Administration,Skin Drug Administration,Transcutaneous Administration,Transdermal Administration,Administration, Dermal,Administration, Transcutaneous,Administration, Transdermal,Cutaneous Administration,Cutaneous Administration, Drug,Dermal Administration,Drug Administration, Cutaneous,Skin Administration, Drug,Administration, Cutaneous Drug,Administration, Dermal Drug,Administration, Percutaneous,Administrations, Cutaneous,Administrations, Cutaneous Drug,Administrations, Dermal,Administrations, Dermal Drug,Administrations, Percutaneous,Administrations, Transcutaneous,Administrations, Transdermal,Cutaneous Administrations,Cutaneous Administrations, Drug,Cutaneous Drug Administrations,Dermal Administrations,Dermal Drug Administrations,Drug Administrations, Cutaneous,Drug Administrations, Dermal,Drug Skin Administrations,Percutaneous Administrations,Skin Administrations, Drug,Skin Drug Administrations,Transcutaneous Administrations,Transdermal Administrations
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D014010 Tinea Versicolor A common chronic, noninflammatory and usually symptomless disorder, characterized by the occurrence of multiple macular patches of all sizes and shapes, and varying in pigmentation from fawn-colored to brown. It is seen most frequently in hot, humid, tropical regions and is mostly caused by MALASSEZIA FURFUR (formerly Pityrosporum orbiculare). Malassezia furfur Infection,Pityriasis Folliculitis,Pityriasis Versicolor,Pityrosporum orbiculare Infection,Folliculitides, Pityriasis,Folliculitis, Pityriasis,Infection, Malassezia furfur,Infection, Pityrosporum orbiculare,Malassezia furfur Infections,Pityriasis Folliculitides,Pityrosporum orbiculare Infections
D016032 Randomized Controlled Trials as Topic Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. Clinical Trials, Randomized,Controlled Clinical Trials, Randomized,Trials, Randomized Clinical

Related Publications

A K Gupta, and R Bluhm, and R Summerbell
March 1973, Meditsinskaia sestra,
A K Gupta, and R Bluhm, and R Summerbell
March 1970, Meditsinskaia sestra,
A K Gupta, and R Bluhm, and R Summerbell
June 1977, The New Zealand medical journal,
A K Gupta, and R Bluhm, and R Summerbell
July 1901, Texas medical journal (Austin, Tex.),
A K Gupta, and R Bluhm, and R Summerbell
April 2015, BMJ (Clinical research ed.),
A K Gupta, and R Bluhm, and R Summerbell
November 1988, Soins; la revue de reference infirmiere,
A K Gupta, and R Bluhm, and R Summerbell
December 1993, Seminars in dermatology,
A K Gupta, and R Bluhm, and R Summerbell
February 1984, La Revue du praticien,
A K Gupta, and R Bluhm, and R Summerbell
December 2011, Medizinische Monatsschrift fur Pharmazeuten,
A K Gupta, and R Bluhm, and R Summerbell
February 1985, Soins; la revue de reference infirmiere,
Copied contents to your clipboard!